CORONAVIRUS
LIVE UPDATES

Effect of COVID-19 on dental professionals in the UKResearchers scramble to understand new SARS-CoV-2 strainsCOVID-19 vaccination: Where does the dental profession stand?Californian dentists allowed to join COVID-19 vaccination effortResearchers develop tent to prevent spread of SARS-CoV-2 in dental settingsCOVID-19 causes major delays in paediatric dental care in Australia“Particularly unsafe” for COVID-19 patients—Sunstar Americas recalls mouthwashWhat is the future of telehealth in dentistry?UK dentists expect drop in earnings, patient numbers in 2021Researchers suggest slower drill rotation to make dental practices safer in pandemic

Visit microsite

ACTEON X-MIND TRIUM – Testimonial Pr Gorni

Back to Americas

Everything ACTEON

17 avenue Gustave Eiffel, BP 30216
MERIGNAC cedex, 33708
France
Tel.: +33 (0) 556 34 06 07
Fax: +33 (0) 556 34 92 92

www.acteongroup.com
info@acteongroup.com

NewsView All

Piezotome extractions favour bone preservation with immediate implant placement

November 02, 2020 | Events, Interviews, News

BORDEAUX, France: Tooth extraction is the most common procedure performed in oral surgery.¹ For example, ten million third molars are removed each year in the US alone, according to the American Public Health Association.² Dentists are ethically committed to using the least traumatic surgical options and least invasive techniques in order to ensure patients’ well-being, thus less traumatic extraction and implant placement are becoming the norm in today’s implant surgery.

Michael Rynerson appointed CEO of ACTEON

June 22, 2020 | Events, Interviews, News

BORDEAUX, France: Michael Rynerson is the new CEO of the dental and medical technology and device manufacturer ACTEON, which is headquartered in France. The supervisory board of Finapolline, the holding company of ACTEON, appointed him to the position effective on 1 June. The chairman of the supervisory board commented that Rynerson has over 25 years of experience, most notably in the dental industry, and possesses the skills to lead the company out of the current health and economic crisis and through its next phase of development.

EXPASYL EXACT: Effective and atraumatic gingival retraction

February 21, 2020 | Events, Interviews, News

CHICAGO, U.S.: Few products have had such a positive effect on dentistry as the EXPASYL gingival retraction paste from ACTEON. After 20 years of clinical research and efficacy, EXPASYL continues to be the choice of many dentists for tissue management during restorative and cosmetic dental treatment. Now, EXPASYL EXACT is available on the market. It offers the same results in the exact amount needed in a cost-effective, single-use capsule that can be used in any composite gun. This means that there will be no more wasted material and there is no need to purchase expensive application guns. At the 155th Chicago Dental Society Midwinter Meeting currently being held in Chicago, interested parties can view the new product at the ACTEON booth (#2811).

WebinarsView All